Gyre Therapeutics (GYRE) Net Cash Flow (QoQ) (2010 - 2026)
Gyre Therapeutics (GYRE) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
104.83% |
| Dec 31, 2025 |
-192.36% |
| Sep 30, 2025 |
-82.66% |
| Jun 30, 2025 |
573.73% |
| Mar 31, 2025 |
183.78% |
| Dec 31, 2024 |
-1,027.00% |
| Sep 30, 2024 |
97.52% |
| Jun 30, 2024 |
-270.04% |
| Mar 31, 2024 |
-118.45% |
| Dec 31, 2023 |
2,732.24% |
| Sep 30, 2023 |
110.03% |
| Jun 30, 2023 |
-40.56% |
| Mar 31, 2023 |
81.43% |
| Dec 31, 2022 |
48.59% |
| Sep 30, 2022 |
-228.90% |
| Jun 30, 2022 |
525.78% |
| Mar 31, 2022 |
35.65% |
| Dec 31, 2021 |
-2.39% |
| Sep 30, 2021 |
-53.50% |
| Jun 30, 2021 |
-117.89% |
